文献速递眼底病与葡萄膜炎

非纤维化瘢痕的五年随访:CATT研究

Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
PubMed 文献 · Ophthalmology · 2018-11-23

基于CATT试验的前瞻性队列研究,描述基线后1年出现非纤维化瘢痕(NFS)的 eyes 在5年时的视力与黄斑形态变化。474只眼中39只(8.2%)在1年有NFS,平均视力80字母(20/25);5年时28%发展为纤维化瘢痕,21%出现地图样萎缩,平均视力73字母(20/32)。结论提示抗VEGF治疗后NFS眼平均视力在5年内保持良好。

要点

  • 1年时NFS占8.2%,平均视力80字母(20/25)。
  • 5年时28%NFS眼发展为纤维化瘢痕,21%出现地图样萎缩。
  • NFS眼5年平均视力73字母(20/32),优于纤维化瘢痕眼(48字母)。

核心结论

  • 抗VEGF治疗后1年出现NFS的眼,平均视力在1、2及5年均保持良好。

研究设计与样本

  • CATT随机临床试验内的前瞻性队列研究,纳入474只于1、2、5年均有图像的 eyes。
  • 参与者随机接受雷珠单抗或贝伐珠单抗及三种给药方案之一,2年后脱离方案,5年时召回。

主要发现

  • 474只眼中39只(8.2%)在1年有NFS,平均视力80字母(Snellen 20/25)。
  • NFS眼纤维化瘢痕发生率2年5%、5年28%;地图样萎缩2年5%、5年21%。
  • NFS眼非地图样萎缩1年34%、2年47%、5年65%。
  • 5年时NFS眼较无瘢痕眼有更少地图样萎缩、更少视网膜内液、更多视网膜下液、更少视网膜下RPE液(均P < 0.01)。
  • NFS眼视网膜、视网膜下组织复合体及总视网膜平均厚度1至5年无变化(P > 0.50),OCT有液比例无变化(P = 0.36),40%眼视网膜下高反射物质5年时消失。

关键数值与推荐

  • NFS定义为1年彩色图像上平坦、小、边界清晰的色素区,伴不同程度中央低色素,不暴露基线CNV处脉络膜血管。
  • 1年有NFS、纤维化瘢痕或无瘢痕的眼5年平均视力分别为73字母(20/32)、48字母(20/100)、62字母(20/63)。

临床怎么用

  • 抗VEGF治疗后1年出现NFS提示5年视力预后较好,可据此与患者沟通。
  • NFS眼仍需长期随访,监测纤维化瘢痕及地图样萎缩的发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe changes in visual acuity (VA) and macular morphologic features at 5 years in eyes with nonfibrotic scar (NFS) identified at 1 year in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). DESIGN: Prospective cohort study within a randomized clinical trial. PARTICIPANTS: Participants in CATT. METHODS: Participants assigned to ranibizumab or bevacizumab and to 1 of 3 dosing regimens were released from the clinical trial protocol after 2 years and recalled at 5 years. Nonfibrotic scar was identified on color images at year 1 as flat, small, well-circumscribed areas of pigmentation with varying degrees of central hypopigmentation without exposure of underlying choroidal vessels at the site of baseline choroidal neovascularization. Follow-up images were assessed for changes in and around NFS. MAIN OUTCOME MEASURES: Pigmentation changes, VA, development of fibrotic scar (FS), nongeographic atrophy (NGA), geographic atrophy (GA), retinal fluid on OCT, and fluorescein leakage. RESULTS: Among 474 eyes with images obtained at 1, 2, and 5 years, 39 (8.2%) showed NFS at 1 year with a mean VA of 80 letters (Snellen equivalent, 20/25). Among these eyes, FS developed in 5% at 2 years and 28% at 5 years. Nongeographic atrophy was observed in 34%, 47%, and 65% of eyes at 1, 2, and 5 years, respectively. Geographic atrophy developed in 5% of eyes at 2 years and 21% at 5 years. Among eyes with NFS, FS, or no scar at 1 year, mean VA at 5 years was 73 letters (20/32), 48 letters (20/100), and 62 letters (20/63), respectively. At 5 years, NFS eyes demonstrated less GA, less intraretinal fluid, more subretinal fluid, and less subretinal pigment epithelium fluid (all P < 0.01). Among NFS eyes, mean thickness of the retina, subretinal tissue complex, and total retina did not change across years 1 to 5 (P > 0.50). The proportion of eyes with fluid on OCT also did not change (P = 0.36). Subretinal hyperreflective material disappeared by 5 years in 40% of eyes with NFS. CONCLUSIONS: These results indicate that, on average, eyes with NFS after anti-VEGF treatment have good VA not only at 1 and 2 years, but also through 5 years.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Daniel E, Ying GS, Kim BJ, et al. Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2018. PMID: 30476517. doi:10.1016/j.ophtha.2018.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。